Negri, Joseph M <br/><br/>
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.  [electronic resource] 

 -  British journal of haematology  Dec 2009 
 - 672-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2009.07891.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinases<br/>Cell Communication--drug effects<br/>Cell Cycle--drug effects<br/>Coculture Techniques<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor--methods<br/>Hematopoietic Stem Cells--cytology<br/>Humans<br/>Multiple Myeloma--pathology<br/>Piperazines--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Tumor Cells, Cultured